Depression pathogenesis and treatment: what can we learn from blood mRNA expression? - Wikidata - awgldk - TriplyDB

Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

http://www.wikidata.org/entity/Q34577617

about

Stress-Related Immune Markers in Depression: Implications for Treatment Type I interferon signaling genes in recurrent major depression: increased expression detected by whole-blood RNA sequencing Cyclooxygenase-2 Signalling Pathway in the Cortex is Involved in the Pathophysiological Mechanisms in the Rat Model of Depression.Identification of commonly altered genes between in major depressive disorder and a mouse model of depression.MicroRNAs 146a/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK/Wnt-system genes.Sympathetic vasomotor tone is associated with depressive symptoms in young females: a potential link between depression and cardiovascular disease.Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression.Blood Transcriptomic Markers in Patients with Late-Onset Major Depressive Disorder Blood-based gene expression signatures of medication-free outpatients with major depressive disorder: integrative genome-wide and candidate gene analyses.Transcriptional signatures related to glucose and lipid metabolism predict treatment response to the tumor necrosis factor antagonist infliximab in patients with treatment-resistant depression.Accumulation of cytoplasmic glucocorticoid receptor is related to elevation of FKBP5 in lymphocytes of depressed patients.The effect of sex and irritable bowel syndrome on HPA axis response and peripheral glucocorticoid receptor expression Transcriptomics in Interferon-α-Treated Patients Identifies Inflammation-, Neuroplasticity- and Oxidative Stress-Related Signatures as Predictors and Correlates of Depression.Preliminary assessment of pre-morbid DNA methylation in individuals at high genetic risk of mood disorders Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties Absolute Measurements of Macrophage Migration Inhibitory Factor and Interleukin-1-β mRNA Levels Accurately Predict Treatment Response in Depressed Patients.Xiangshao Granule Exerts Antidepressive Effects in a Depression Mouse Model by Ameliorating Deficits in Hippocampal BDNF and TrkB.Genetic Contributions of Inflammation to Depression.Identifying a gene expression signature of cluster headache in blood Consequences of cancer treatments on adult hippocampal neurogenesis: implications for cognitive function and depressive symptoms Gene expression-based biological test for major depressive disorder: an advanced study.Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses.The promise of biomarkers in diagnosing major depression in primary care: the present and future.Early life trauma, depression and the glucocorticoid receptor gene--an epigenetic perspective.PDE4B as a microglia target to reduce neuroinflammation.Increased levels of 5HT2A receptor mRNA expression in peripheral blood mononuclear cells of patients with major depression: correlations with severity and duration of illness.Gene expression in major depressive disorder.Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy.Peripheral blood microRNA and VEGFA mRNA changes following electroconvulsive therapy: implications for psychotic depression.Seeking an objective diagnosis of depression.Effect of escitalopram versus placebo on GRα messenger RNA expression in peripheral blood cells of healthy individuals with a family history of depression - a secondary outcome analysis from the randomized AGENDA trial.Effects of sevoflurane on NF-кB and TNF-α expression in renal ischemia-reperfusion diabetic rats.

P2860

Q26771607-91E51CC6-C0C2-440B-BEDF-AAE48E1245FE Q33603049-6E40E83E-8A99-471F-9C0B-66FC37AA0F76 Q33674243-DD778E3B-FD4B-4592-9E10-64BD3ED88DE4 Q33780372-5CADB288-0193-4BBB-AB58-296560DA0BFA Q33815733-F45B0832-8128-4C41-BF96-65783A9C23C5 Q34037802-948E1127-31B0-4BBF-AC57-AF9D469984C8 Q34624634-C762DF30-5C73-45A9-88C4-CABC552BF2FE Q35939562-E095C369-E63E-40A1-8376-0C5C3E154B27 Q36427831-8228F0C4-2B2E-481C-9CCD-7CE77B74577B Q36905880-5DF68DDD-0426-4AAD-9FB5-5DB22B456586 Q36940000-44A7F8B5-0328-499A-99F8-29A2BC8BC88B Q37158747-424646F0-95A1-4FD0-BDEC-A33C05C245B5 Q37171783-61DE1996-10B4-4004-9E09-B9959137144B Q37221976-CEDC6A2A-773A-4436-ADD3-63D6106A19AA Q37330681-B646330D-14B4-4974-A2A8-726311587A66 Q37388467-66602AD4-4CF8-47DB-9F07-3D3E49593340 Q37400444-5EC35292-5743-457C-8244-6D36AE79733C Q37483043-5E1816A5-D79E-46CF-8DA3-04035715F1F9 Q37579127-11837B94-EB29-4846-A0D5-E93105DB67CB Q37641257-65D1596B-7540-438D-8D26-64B672D2DB1A Q37669886-2391A920-A2CD-43AA-8C2E-5A70D2B316EB Q38366733-33956B13-B7E3-4B2F-9D0A-8FD401FB57CB Q38529746-1D7CAC15-3DA4-47FC-AF7B-315B3E61E171 Q38589868-B0D094E8-6BD1-45D3-82F9-3A0EF8BC2BDD Q38796315-58748A81-2025-4C83-A027-3DAAF76A968C Q38997609-D335DDE1-FF9A-4273-B5A9-4B51D372C20E Q40904308-8FDBDDFC-1934-4376-9FA6-8452740690DD Q41753839-C22EAA05-50BD-473C-94E5-FD6C4A956D7E Q47750361-F0C5BDDA-B8A7-4E99-9143-536D1991FED8 Q48048867-026B0D45-E5F0-4EBB-960F-6CA0EC2B3E9E Q48066672-DA78A32E-C8A1-4CED-8AE4-F2AB48C4F2A4 Q52763326-72CFAF8B-FDF8-4236-81C2-C8F8946CB26F

P2860

Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

http://www.wikidata.org/entity/Q34577617

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

@ast

Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

@en

Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

@nl

type

label

Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

@ast

Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

@en

Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

@nl

prefLabel

Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

@ast

Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

@en

Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

@nl

P1433

Q34577617-66534766-44D3-47D7-8267-85493081C8D7

P1476

Q34577617-122D0635-848F-4EA2-9AA4-2456DE485D68

P2093

Q34577617-79189937-34C4-4FBD-B357-D5337C4079CE

P2860

Q34577617-120C8E28-781E-449E-AE42-5979AD637ADC

Q34577617-1261E6A6-976D-4B28-9B49-55205654DA09

Q34577617-12BE98E6-C5F0-4B4B-8CD9-DEA3F8EA9927

Q34577617-15217F94-3186-41CE-B268-33A41C2F4862

Q34577617-155396C1-7DDD-4D2A-8E5B-1647CDA125D4

Q34577617-186FB942-2C55-4E66-BF96-3D090BF4DE6A

Q34577617-1D84A2C9-491F-4844-B447-1C4D8CE11D89

Q34577617-2715EB45-CA16-4A5B-A43D-44D2F9C0E95F

Q34577617-289B371C-9901-4CAD-ABA3-A6036F85CF8A

Q34577617-298D9E6D-FD39-43B7-8460-9A11EC383F91

P2888

Q34577617-F7CFA204-4498-4577-892D-2CF368389171

P304

Q34577617-F06D1DEE-6FC4-4FAA-817E-469A91D7E3A4

P31

Q34577617-90CAEEB0-DE29-4099-B88E-CB2496294103

P356

Q34577617-E47CAC38-535D-47D9-9B8F-515B429A78C3

P407

Q34577617-40B76946-B377-43D0-8A99-B93D4A35D1D4

P478

Q34577617-43D3C0FC-1D04-4733-9FD3-43248559F539

P50

Q34577617-30AF30E3-E1E6-4B0B-8D3D-8330152D0F50

Q34577617-59C59ED1-C0C3-4E27-83CD-751824671FDC

Q34577617-8EDFFD9D-F1A4-48AA-B77E-F406A7DDE689

P577

Q34577617-F83A2F80-C49E-40A8-835C-9FA46480C648

P5875

Q34577617-BB32602F-647D-441A-9E52-24383EECF05F

P6179

Q34577617-D275C007-9D45-4F75-BBB1-F2D813D5D995

P698

Q34577617-BA013603-6E6C-4C6E-84B5-50ECF66B8940

P932

Q34577617-FE256100-B648-4EEA-99F8-329B0ACE5605

P356

1741-7015-11-28

P1433

P1476

Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

@en

P2093

Nilay Hepgul

http://www.w3.org/2001/XMLSchema#string

P2860

The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis

Regulation of aldosterone and cortisol production by the transcriptional repressor neuron restrictive silencer factor

The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes

The regulatory chain in the p36-kd substrate complex of viral tyrosine-specific protein kinases is related in sequence to the S-100 protein of glial cells

Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity

SCFbeta-TRCP controls oncogenic transformation and neural differentiation through REST degradation

Peripheral monocytes from diabetic patients with coronary artery disease display increased bFGF and VEGF mRNA expression

Altered expression of neurotrophic factors in patients with major depression

Reduced expression of apolipoprotein E receptor type 2 in peripheral blood lymphocytes from patients with major depressive disorder

Alterations in 5-HT1B receptor function by p11 in depression-like states

P2888

1741-7015-11-28

P304

28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1741-7015-11-28

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Annamaria Cattaneo

Patricia A Zunszain

Carmine Pariante

P577

2013-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

235404124

http://www.w3.org/2001/XMLSchema#string

P6179

1006504619

http://www.w3.org/2001/XMLSchema#string

P698

23384232

http://www.w3.org/2001/XMLSchema#string

P932

3606439

http://www.w3.org/2001/XMLSchema#string